EFAVIRENZ

Substance profile for UNII JE6H2O27P8, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Chemical structure for EFAVIRENZ
Structure render from PubChem CID 64139

Substance Identity#

UNII
JE6H2O27P8
Preferred term
EFAVIRENZ
Registry number
154598-52-4
Ingredient type
INGREDIENT SUBSTANCE
Molecular formula
C14H9ClF3NO2
Chemical structure for EFAVIRENZ
Structure render from PubChem CID 64139

Chemical And Database Identifiers#

InChIKey
XPOQHMRABVBWPR-ZDUSSCGKSA-N
SMILES
FC(F)(F)[C@]1(OC(=O)NC2=CC=C(Cl)C=C12)C#CC3CC3
RxCUI
195085
PubChem
64139
NCIt
C29027
INN ID
7718

Open Chemistry Sources#

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
EFAVIRENZACTIVE INGREDIENTJE6H2O27P8These highlights do not include all the information needed to use ATRIPLA safely and effectively. See full prescribing information for ATRIPLA. ATRIPLA ® (efavirenz/emtricitabine/tenofovir disoproxil fumarate) tablets, for oral use Initial U.S. Approval: 20063
EFAVIRENZACTIVE MOIETYJE6H2O27P8These highlights do not include all the information needed to use ATRIPLA safely and effectively. See full prescribing information for ATRIPLA. ATRIPLA ® (efavirenz/emtricitabine/tenofovir disoproxil fumarate) tablets, for oral use Initial U.S. Approval: 20063
efavirenzACTIVE MOIETYJE6H2O27P8These highlights do not include all the information needed to use SUSTIVA safely and effectively. See full prescribing information for SUSTIVA. SUSTIVA ® (efavirenz) capsules for oral use SUSTIVA ® (efavirenz) tablets for oral use Initial U.S. Approval: 19982
efavirenzACTIVE INGREDIENTJE6H2O27P8These highlights do not include all the information needed to use SUSTIVA safely and effectively. See full prescribing information for SUSTIVA. SUSTIVA ® (efavirenz) capsules for oral use SUSTIVA ® (efavirenz) tablets for oral use Initial U.S. Approval: 19982
efavirenzACTIVE INGREDIENTJE6H2O27P8SUSTIVA (EFAVIRENZ) CAPSULE, GELATIN COATED SUSTIVA (EFAVIRENZ) CAPSULE, GELATIN COATED SUSTIVA (EFAVIRENZ) TABLET, FILM COATED [BRISTOL-MYERS SQUIBB PHARMA COMPANY]24
efavirenzACTIVE MOIETYJE6H2O27P8SUSTIVA (EFAVIRENZ) CAPSULE, GELATIN COATED SUSTIVA (EFAVIRENZ) CAPSULE, GELATIN COATED SUSTIVA (EFAVIRENZ) TABLET, FILM COATED [BRISTOL-MYERS SQUIBB PHARMA COMPANY]24
EFAVIRENZACTIVE INGREDIENTJE6H2O27P8ATRIPLA (EFAVIRENZ, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE) TABLET, FILM COATED [BRISTOL MYERS SQUIBB & GILEAD SCIENCES, LLC]17
EFAVIRENZACTIVE MOIETYJE6H2O27P8ATRIPLA (EFAVIRENZ, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE) TABLET, FILM COATED [BRISTOL MYERS SQUIBB & GILEAD SCIENCES, LLC]17
EFAVIRENZACTIVE INGREDIENTJE6H2O27P8ATRIPLA (EFAVIRENZ, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE) TABLET, FILM COATED [STATE OF FLORIDA DOH CENTRAL PHARMACY]2
efavirenzACTIVE MOIETYJE6H2O27P8ATRIPLA (EFAVIRENZ, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE) TABLET, FILM COATED [STATE OF FLORIDA DOH CENTRAL PHARMACY]2
efavirenzACTIVE MOIETYJE6H2O27P8ATRIPLA (EFAVIRENZ, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE) TABLET, FILM COATED [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]1
efavirenzACTIVE INGREDIENTJE6H2O27P8ATRIPLA (EFAVIRENZ, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE) TABLET, FILM COATED [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]1
EFAVIRENZACTIVE INGREDIENTJE6H2O27P8ATRIPLA (EFAVIRENZ, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE) TABLET, FILM COATED [REMEDYREPACK INC. ]1
EFAVIRENZACTIVE MOIETYJE6H2O27P8ATRIPLA (EFAVIRENZ, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE) TABLET, FILM COATED [REMEDYREPACK INC. ]1
EFAVIRENZACTIVE MOIETYJE6H2O27P8ATRIPLA ACCESS (EFAVIRENZ, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE) TABLET, FILM COATED [GILEAD SCIENCES, INC.]1
EFAVIRENZACTIVE INGREDIENTJE6H2O27P8ATRIPLA ACCESS (EFAVIRENZ, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE) TABLET, FILM COATED [GILEAD SCIENCES, INC.]1